Alsumali相关文献与解析，生知库 | 链接生命科学的每一步

The Potential Impact of Sotatercept on Long-Term Disability in Commercially Insured Patients with Pulmonary Arterial Hypertension in the United States: An Exercise in Actuarial Modeling

索他西普对美国商业保险肺动脉高压患者长期残疾的潜在影响：精算建模练习

Watzker, Anna; Alsumali, Adnan; Ferro, Christine; Li, Xun Jun; Dieguez, Gabriela; Park, Clare; Chevure, Jestinah; Lautsch, Dominik; El-Kersh, Karim

肺动脉高压

心血管

发表日期：2025

文献求助收藏

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model

延迟使用索他西普对肺动脉高压（PAH）患者长期死亡率和发病率的影响：模拟模型

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-025-03241-4

Alsumali, Adnan; McLaughlin, Vallerie; Chevure, Jestinah; Klok, Rogier; Zhang, Wenjie; Martinez, Eliana C; Pausch, Christine; De Oliveira Pena, Janethe; van de Wetering, Gijs; Jootun, Murvin; Lautsch, Dominik; Hoeper, Marius M

Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)

人口健康模型预测索他西普对肺动脉高压（PAH）患者发病率和死亡率的长期影响

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-023-02684-x

McLaughlin, Vallerie; Alsumali, Adnan; Liu, Rongzhe; Klok, Rogier; Martinez, Eliana C; Nourhussein, Iman; Bernotas, David; Chevure, Jestinah; Pausch, Christine; De Oliveira Pena, Janethe; Lautsch, Dominik; Hoeper, Marius M

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

更正：美国成人门诊COVID-19患者莫努匹韦与最佳支持疗法治疗的成本效益分析

期刊:Pharmacoeconomics

影响因子:4.6

doi:10.1007/s40273-023-01263-w

Goswami, Hardik; Alsumali, Adnan; Jiang, Yiling; Schindler, Matthias; Duke, Elizabeth R; Cohen, Joshua; Briggs, Andrew; Puenpatom, Amy

发表日期：2023

文献求助收藏

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

美国成人门诊COVID-19患者使用莫努匹韦与最佳支持疗法治疗的成本效益分析

期刊:Pharmacoeconomics

影响因子:4.6

doi:10.1007/s40273-022-01168-0

Goswami, Hardik; Alsumali, Adnan; Jiang, Yiling; Schindler, Matthias; Duke, Elizabeth R; Cohen, Joshua; Briggs, Andrew; Puenpatom, Amy

发表日期：2022

文献求助收藏

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

口服索马鲁肽强化治疗与西格列汀治疗对美国二甲双胍治疗控制不佳的2型糖尿病患者的预算影响

期刊:Pharmacoeconomics

影响因子:4.6

doi:10.1007/s40273-020-00967-7

Wehler, Elizabeth; Lautsch, Dominik; Kowal, Stacey; Davies, Glenn; Briggs, Andrew; Li, Qianyi; Rajpathak, Swapnil; Alsumali, Adnan

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective

从美国医疗保险角度评估维利西呱治疗射血分数降低的慢性心力衰竭（发生恶化性心力衰竭事件后）的成本效益

期刊:Pharmacoeconomics

影响因子:4.6

doi:10.1007/s40273-021-01091-w

Alsumali, Adnan; Djatche, Laurence M; Briggs, Andrew; Liu, Rongzhe; Diakite, Ibrahim; Patel, Dipen; Wang, Yufei; Lautsch, Dominik

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

维利西呱治疗射血分数降低的慢性心力衰竭恶化事件后的预算影响分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-021-01681-2

Alsumali, Adnan; Lautsch, Dominik; Liu, Rongzhe; Patel, Dipen; Nanji, Sakina; Djatche, Laurence M

Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis

二甲双胍单药治疗血糖控制不佳的2型糖尿病患者，联合使用两种或两种口服降糖药的疗效比较：系统文献综述和网络荟萃分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-020-00975-y

Lautsch, Dominik; Alsumali, Adnan; McLeod, Euan; Kuang, Yuting; He, Jing; Singh, Rajpal; Nevo, Arianna; Arnet, Urs; Uyei, Jennifer; Rajpathak, Swapnil

Economic Burden Associated with Pulmonary Arterial Hypertension in the United States

美国肺动脉高压相关的经济负担

The Potential Impact of Sotatercept on Long-Term Disability in Commercially Insured Patients with Pulmonary Arterial Hypertension in the United States: An Exercise in Actuarial Modeling

索他西普对美国商业保险肺动脉高压患者长期残疾的潜在影响：精算建模练习

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model

延迟使用索他西普对肺动脉高压（PAH）患者长期死亡率和发病率的影响：模拟模型

Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)

人口健康模型预测索他西普对肺动脉高压（PAH）患者发病率和死亡率的长期影响

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

更正：美国成人门诊COVID-19患者莫努匹韦与最佳支持疗法治疗的成本效益分析

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

美国成人门诊COVID-19患者使用莫努匹韦与最佳支持疗法治疗的成本效益分析

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

口服索马鲁肽强化治疗与西格列汀治疗对美国二甲双胍治疗控制不佳的2型糖尿病患者的预算影响

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective

从美国医疗保险角度评估维利西呱治疗射血分数降低的慢性心力衰竭（发生恶化性心力衰竭事件后）的成本效益

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

维利西呱治疗射血分数降低的慢性心力衰竭恶化事件后的预算影响分析

Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis

二甲双胍单药治疗血糖控制不佳的2型糖尿病患者，联合使用两种或两种口服降糖药的疗效比较：系统文献综述和网络荟萃分析